XML 27 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Agreements and Commitments
6 Months Ended
Jun. 30, 2020
Significant Agreements And Commitments Disclosure [Abstract]  
Significant Agreements and Commitments

8. Significant Agreements and Commitments

In March 2020, the Company executed a strategic collaboration with The University of Texas M. D. Anderson Cancer Center (“MDACC”). The collaboration will consist of preclinical studies and clinical trials designed by the Company and MDACC with the research conducted by MDACC. The Company has agreed to commit $10,000 in funding for various studies over a period of five years, of which $2,000 was paid in April 2020.

In June 2020, the Company procured a directors and officers (D&O) liability insurance for a total aggregate premium of $6,420, including excise tax, of which $270 has been recognized as accrued expenses and other current liabilities as of June 30, 2020, with a corresponding increase in general and administrative expenses. The total aggregate premium of D&O insurance in the amount of $6,420 was paid and $6,150 was recorded as prepaid expenses and other current assets in July 2020.